RMD price target
ResMed Inc. · end-of-day data as of Oct 16, 2026
ResMed Inc.
$238.97+22.7%
Buy · 20 analystsPT $247.91 +3.7%
The average price target of the 12 analyst firms that published one in the last 12 months is $247.91 for RMD, 3.7% above the last close of $238.97 on Oct 16, 2026. Targets range from $210.15 to $298.88, with a median of $248.06. Rating consensus: Buy.
Summary
- Target upside+3.7%
- ConsensusBuy
Analyst price targets
Low$210.15
Average$247.91
Median$248.06
High$298.88
Upside+3.7%
12 firms with a target in the last 12 months · last close $238.97 · as of Oct 16, 2026
Stifel Nicolaus$2542025-12-18
Robert W. Baird$2672025-12-16
UBS$3432025-12-12
Robert W. Baird$2992025-11-03
KeyBanc$2992025-10-31
Morgan Stanley$2952025-10-31
+1 more
KeyBanc$3002026-01-30
Piper Sandler$2742026-01-30
RBC Capital$3172026-01-30
Robert W. Baird$2792026-01-30
Stifel Nicolaus$2642026-01-30
Robert W. Baird$2252026-05-01
KeyBanc$2912026-04-27
Evercore ISI$2562026-04-13
KeyBanc$2672026-08-31
Redburn Partners$2402026-08-19
KeyBanc$2412026-08-07
Robert W. Baird$2122026-08-07
RBC Capital$2382026-07-16
Mizuho Securities$2262026-07-15
+4 more
UBS$2992026-07-21
KeyBanc$2652026-06-22
Mizuho Securities$2402026-10-13
RBC Capital$2702026-09-15
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets
Strong buy 2 · Buy 7 · Hold 10 · Sell 1 · Strong sell 0